Literature DB >> 11433065

Experience with the ketogenic diet in infants.

D R Nordli1, M M Kuroda, J Carroll, D Y Koenigsberger, L J Hirsch, H J Bruner, W T Seidel, D C De Vivo.   

Abstract

OBJECTIVE: To evaluate the effectiveness, tolerability, and adverse effects of the ketogenic diet in infants with refractory epilepsy.
METHODS: A retrospective review of 32 infants who had been treated with the ketogenic diet at a large metropolitan institution.
RESULTS: Most infants (71%) were able to maintain strong ketosis. The overall effectiveness of the diet in infants was similar to that reported in the literature for older children; 19.4% became seizure-free, and an additional 35.5% had >50% reduction in seizure frequency. The diet was particularly effective for patients with infantile spasms/myoclonic seizures. There were concomitant reductions in antiepileptic medications. The majority of parents reported improvements in seizure frequency and in their child's behavior and function, particularly with respect to attention/alertness, activity level, and socialization. The diet generally was well-tolerated, and 96.4% maintained appropriate growth parameters. Adverse events, all reversible and occurring in one patient each, included renal stone, gastritis, ulcerative colitis, alteration of mentation, and hyperlipidemia.
CONCLUSION: The ketogenic diet should be considered safe and effective treatment for infants with intractable seizures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433065     DOI: 10.1542/peds.108.1.129

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

1.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

Review 2.  State of the ketogenic diet(s) in epilepsy.

Authors:  Jennifer Huffman; Eric H Kossoff
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

3.  Protection of hypoglycemia-induced neuronal death by β-hydroxybutyrate involves the preservation of energy levels and decreased production of reactive oxygen species.

Authors:  Alberto Julio-Amilpas; Teresa Montiel; Eva Soto-Tinoco; Cristian Gerónimo-Olvera; Lourdes Massieu
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-04       Impact factor: 6.200

4.  Male mice placed on a ketogenic diet from postnatal day (P) 21 through adulthood have reduced growth, are hypoactive, show increased freezing in a conditioned fear paradigm, and have spatial learning deficits.

Authors:  Keila N Miles; Matthew R Skelton
Journal:  Brain Res       Date:  2020-01-31       Impact factor: 3.252

Review 5.  Dietary therapies for epilepsy: future research.

Authors:  Sudha K Kessler; Elizabeth G Neal; Carol S Camfield; Eric H Kossoff
Journal:  Epilepsy Behav       Date:  2011-03-26       Impact factor: 2.937

Review 6.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

Review 7.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

8.  Introduction of a ketogenic diet in young infants.

Authors:  J Klepper; B Leiendecker; R Bredahl; S Athanassopoulos; F Heinen; E Gertsen; A Flörcken; A Metz; T Voit
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

9.  Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration.

Authors:  K-K Tai; N Nguyen; L Pham; D D Truong
Journal:  J Neural Transm (Vienna)       Date:  2008-05-14       Impact factor: 3.575

Review 10.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Authors:  Marwan Maalouf; Jong M Rho; Mark P Mattson
Journal:  Brain Res Rev       Date:  2008-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.